Pfizer Beats Sandoz In IP Suit Over Generic Eye Drug

Pfizer Beats Sandoz In IP Suit Over Generic Eye Drug

A New Jersey federal judge ruled Friday that Sandoz Inc. violated four patents owned by Pfizer Inc. and InSite Vision Inc. when it tried to bring to market a generic version of AzaSite azithromycin eye drops, which are used as a bacterial conjunctivitis ...read more

  • Tags: